MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging

AJR. American Journal of Roentgenology
F FazekasR A Zimmerman


The type, frequency, and extent of MR signal abnormalities in Alzheimer's disease and normal aging are a subject of controversy. With a 1.5-MR unit we studied 12 Alzheimer patients, four subjects suffering from multiinfarct dementia and nine age-matched controls. Punctate or early confluent high-signal abnormalities in the deep white matter, noted in 60% of both Alzheimer patients and controls, were unrelated to the presence of hypertension or other vascular risk factors. A significant number of Alzheimer patients exhibited a more extensive smooth "halo" of periventricular hyperintensity when compared with controls (p = .024). Widespread deep white-matter hyperintensity (two patients) and extensive, irregular periventricular hyperintensity (three patients) were seen in multiinfarct dementia. Areas of high signal intensity affecting hippocampal and sylvian cortex were also present in five Alzheimer and two multiinfarct dementia patients, but absent in controls. Discrete, small foci of deep white-matter hyperintensity are not characteristic of Alzheimer's disease nor do they appear to imply a vascular cause for the dementing illness. The frequently observed "halo" of periventricular hyperintensity in Alzheimer's disease may be of...Continue Reading


Jun 1, 1991·Italian Journal of Neurological Sciences·M Mascalchi, D Inzitari
Oct 1, 1990·Journal of Neuro-oncology·L M DeAngelis
Jul 3, 2002·Aging Clinical and Experimental Research·Pierre PfitzenmeyerChristelle Mischis-Troussard
Dec 25, 2007·Diabetologia·K WeingerP F Renshaw
Dec 25, 2009·Neuroradiology·Wataru GonoiKuni Ohtomo
Oct 12, 2012·Neuroradiology·Zareen FatimaTsutomu Araki
Jan 8, 2013·Neuroradiology·Teemu PaavilainenRiitta Parkkola
Nov 2, 2012·European Radiology·Benjamin S AribisalaJoanna M Wardlaw
Jun 28, 2011·Acta Neuropathologica·Reinhold SchmidtKurt Jellinger
Nov 4, 2010·Archives of Gynecology and Obstetrics·Kook Jin AhnIn Yong Whang
Nov 9, 2007·European Archives of Psychiatry and Clinical Neuroscience·Shogo KomakiJotaro Akiyoshi
Jun 10, 2008·Journal of Neurology·Beom Joon KimJae-Kyu Roh
Jun 26, 2008·Journal of Neurology·Marc RousseauxOdile Kozlowski
Jul 21, 2009·Journal of Neurology·Young-Hee SungByung-Chul Lee
Aug 26, 2009·Journal of Neurology·Felicia B AxelrodAntonio Convit
Apr 25, 2012·Journal of Neurology·Katrin WasserAndreas Kastrup
Aug 3, 2012·Journal of Neurology·Daniela LiebermannChristoph J Ploner
Sep 7, 2013·Journal of Neurology·Kyoung Jin HwangDeog Yoon Kim
Mar 31, 2011·Journal of Anesthesia·Kengo MaekawaTatsuo Yamamoto
Oct 8, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·S MaeshimaN Tanahashi
Jan 20, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Laura CiolliLeonardo Pantoni
May 29, 2012·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Bora YoonDong-Won Yang
May 12, 2007·The Psychiatric Quarterly·Joseph Tonkonogy, Jeffrey Geller

Related Concepts

Senile Paranoid Dementia
In Vivo NMR Spectroscopy
Cortex Bone Disorders
Adrenal Cortex Diseases
Blood Vessel
Alzheimer's Disease
Alport Syndrome, Mental Retardation, Midface Hypoplasia, and Elliptocytosis
Structure of Cortex of Kidney

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.